View in EDS HTML Full Text PDF Full Text

An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer.

Saved in:
Bibliographic Details
Title: An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer.
Authors: Lim E; Garvan Institute of Medical Research, St. Vincent's Clinical School, University of New South Wales, 370 Victoria Street, Darlinghurst, NSW, Australia. e.lim@garvan.org.au., Boyle F; Mater Hospital, North Sydney, NSW, Australia., Okera M; Adelaide Cancer Centre, Kurralta Park, SA, Australia., Loi S; Peter MacCallum Cancer Centre, Melbourne, VI, Australia., Goksu SS; Akdeniz University Medical Faculty, Antalya, Turkey., van Hal G; Eli Lilly and Company, Utrecht, Netherlands., Chapman SC; Eli Lilly and Company, Windlesham, Surrey, UK., Gable JC; Eli Lilly and Company, Indianapolis, IN, USA., Chen Y; Eli Lilly and Company, Indianapolis, IN, USA., Price GL; Eli Lilly and Company, Indianapolis, IN, USA., Hossain AM; Eli Lilly and Company, Indianapolis, IN, USA., Gainford MC; Eli Lilly and Company, Indianapolis, IN, USA., Ezquerra MB; Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Oct; Vol. 195 (3), pp. 275-287. Date of Electronic Publication: 2022 Aug 01.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35915198
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lim+E%22">Lim E</searchLink>; Garvan Institute of Medical Research, St. Vincent's Clinical School, University of New South Wales, 370 Victoria Street, Darlinghurst, NSW, Australia. e.lim@garvan.org.au.<br /><searchLink fieldCode="AU" term="%22Boyle+F%22">Boyle F</searchLink>; Mater Hospital, North Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Okera+M%22">Okera M</searchLink>; Adelaide Cancer Centre, Kurralta Park, SA, Australia.<br /><searchLink fieldCode="AU" term="%22Loi+S%22">Loi S</searchLink>; Peter MacCallum Cancer Centre, Melbourne, VI, Australia.<br /><searchLink fieldCode="AU" term="%22Goksu+SS%22">Goksu SS</searchLink>; Akdeniz University Medical Faculty, Antalya, Turkey.<br /><searchLink fieldCode="AU" term="%22van+Hal+G%22">van Hal G</searchLink>; Eli Lilly and Company, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Chapman+SC%22">Chapman SC</searchLink>; Eli Lilly and Company, Windlesham, Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Gable+JC%22">Gable JC</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Price+GL%22">Price GL</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Hossain+AM%22">Hossain AM</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Gainford+MC%22">Gainford MC</searchLink>; Eli Lilly and Company, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Ezquerra+MB%22">Ezquerra MB</searchLink>; Hospital Universitario Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2022 Oct; Vol. 195 (3), pp. 275-287. <i>Date of Electronic Publication: </i>2022 Aug 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35915198
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10549-022-06690-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 275
    Titles:
      – TitleFull: An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lim E
      – PersonEntity:
          Name:
            NameFull: Boyle F
      – PersonEntity:
          Name:
            NameFull: Okera M
      – PersonEntity:
          Name:
            NameFull: Loi S
      – PersonEntity:
          Name:
            NameFull: Goksu SS
      – PersonEntity:
          Name:
            NameFull: van Hal G
      – PersonEntity:
          Name:
            NameFull: Chapman SC
      – PersonEntity:
          Name:
            NameFull: Gable JC
      – PersonEntity:
          Name:
            NameFull: Chen Y
      – PersonEntity:
          Name:
            NameFull: Price GL
      – PersonEntity:
          Name:
            NameFull: Hossain AM
      – PersonEntity:
          Name:
            NameFull: Gainford MC
      – PersonEntity:
          Name:
            NameFull: Ezquerra MB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2022 Oct
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7217
          Numbering:
            – Type: volume
              Value: 195
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Breast cancer research and treatment
              Type: main
ResultId 1